Scholarlink

Background <p>Blood disorders in children can present with a wide range of nonspecific symptoms, which may overlap with other conditions. Traditional diagnostic methods can sometimes struggle to identify the underlying cause. Whole-exome sequencing (WES)—is increasingly recognized as a valuable diagnostic tool, as early genetic diagnosis can offer clarity, enabling more personalized treatment approaches and improving prognostic accuracy.</p> Methods <p>Between January 2022 and December 2024, 67 patients at the pediatric hematology department of Maternity and Children Hospital in Makkah, Saudi Arabia, underwent WES after conventional diagnostic methods failed to provide definitive diagnoses. We retrospectively analysed their results.</p> Results <p>The study included 67 patients with an average age of 6.5 ± 4.6 years (range 0.1–18 years), 53% of whom were male. The majority (88%) were of Saudi descent. WES provided a molecular diagnosis for 49% (<i>n</i> = 33) of the patients, identifying pathogenic or likely pathogenic variants. In 11% (<i>n</i> = 8) of the patients, no variants were found, whereas 38% (<i>n</i> = 26) had variants of uncertain significance in phenotype-related genes. A nonhematological diagnosis was given to 28% of the patients.</p> Conclusion <p>Whole-exome sequencing is a valuable tool for diagnosing challenging pediatric blood disorders. The findings also underscore its importance in identifying complex or multifactorial disorders.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A single-center study: three years of experience with whole-exome sequencing in diagnosing pediatric hematological disorders

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月9日

查看全文
  • Shaimaa Salah,
  • Amira Mobarak,
  • Saleh Nouh Alshanbari,
  • Asem A. Bukhari,
  • Fouzia Alsobhi,
  • Sally Abdelazim Ali Farahat,
  • Hassan Musa Masmali

摘要

Background

Blood disorders in children can present with a wide range of nonspecific symptoms, which may overlap with other conditions. Traditional diagnostic methods can sometimes struggle to identify the underlying cause. Whole-exome sequencing (WES)—is increasingly recognized as a valuable diagnostic tool, as early genetic diagnosis can offer clarity, enabling more personalized treatment approaches and improving prognostic accuracy.

Methods

Between January 2022 and December 2024, 67 patients at the pediatric hematology department of Maternity and Children Hospital in Makkah, Saudi Arabia, underwent WES after conventional diagnostic methods failed to provide definitive diagnoses. We retrospectively analysed their results.

Results

The study included 67 patients with an average age of 6.5 ± 4.6 years (range 0.1–18 years), 53% of whom were male. The majority (88%) were of Saudi descent. WES provided a molecular diagnosis for 49% (n = 33) of the patients, identifying pathogenic or likely pathogenic variants. In 11% (n = 8) of the patients, no variants were found, whereas 38% (n = 26) had variants of uncertain significance in phenotype-related genes. A nonhematological diagnosis was given to 28% of the patients.

Conclusion

Whole-exome sequencing is a valuable tool for diagnosing challenging pediatric blood disorders. The findings also underscore its importance in identifying complex or multifactorial disorders.